0000950170-24-026522.txt : 20240305
0000950170-24-026522.hdr.sgml : 20240305
20240305185707
ACCESSION NUMBER: 0000950170-24-026522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Booth Bruce
CENTRAL INDEX KEY: 0001451612
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 24723372
MAIL ADDRESS:
STREET 1: 890 WINTER STREET
STREET 2: SUITE 320
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vigil Neuroscience, Inc.
CENTRAL INDEX KEY: 0001827087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FORGE ROAD
STREET 2: SUITE 700
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-254-4445
MAIL ADDRESS:
STREET 1: 100 FORGE ROAD
STREET 2: SUITE 700
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
ownership.xml
4
X0508
4
2024-03-01
0001827087
Vigil Neuroscience, Inc.
VIGL
0001451612
Booth Bruce
VIGIL NEUROSCIENCE, INC.
100 FORGE ROAD, SUITE 700
WATERTOWN
MA
02472
true
false
false
false
false
Stock Option Grant (Right to Buy)
3.39
2024-03-01
4
A
false
34612
0.00
A
2034-03-01
Common Stock
34612
34612
D
This option was awarded to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of cash compensation. The shares subject to this option shall vest and become exercisable in four equal quarterly installments on the last day of each calendar quarter, with the first installment vesting on March 31, 2024.
The Reporting Person is a member of Atlas Venture Associates XII, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
/s/ Ommer Chohan, Attorney-in-Fact
2024-03-05